Navigation Links
Tengion Announces Pricing of $31.4 Million Private Placement
Date:3/1/2011

EAST NORRITON, Pa., March 1, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that it has entered into definitive agreements with certain investors in connection with a PIPE financing transaction pursuant to registration exemptions under the Securities Act of 1933, as amended.  Medtronic (NYSE: MDT), a global leader in medical technology, participated in the financing and, as part of its investment, secured a right of first refusal on Tengion's lead preclinical program, the Neo-Kidney Augment™, through October 31, 2013. Upon the closing of the transaction, Tengion will receive gross proceeds of $31.4 million in exchange for the issuance to such investors of 11,079,250 shares of Tengion common stock and warrants to purchase 10,460,875 shares of Tengion common stock. The warrants will be exercisable for a period of five years from the date of their issuance at an exercise price of $2.88 per share. The closing of the transaction, which is subject to customary closing conditions, is scheduled to occur on or prior to March 4, 2011. Tengion intends to use the net proceeds of the transaction to fund research and development activities primarily related to the Company's Neo-Urinary Conduit and Neo-Kidney Augment Programs, for repayment of debt, and for working capital and other general corporate purposes.

Piper Jaffray & Co. served as the sole lead placement agent and Leerink Swann LLC served as co-placement agent for the transaction.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the secu
'/>"/>

SOURCE Tengion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tengion Addresses Recent Trading Activity in its Common Stock
2. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
3. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
4. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
5. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
6. Tengion Appoints A. Brian Davis Chief Financial Officer
7. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
8. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
9. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
10. Tengion Announces Second Closing of Series C Financing
11. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... $1.4 million bringing Q3 orders to date to $5 million. ... North America . "We continue to see ... and CEO. "With these orders, our backlog has climbed to ... BIOREM is a leading clean technology company that designs, ...
(Date:9/23/2014)... Cambridge Semantics, the leading provider of Smart Data ... the recent ‘Hype Cycle for Life Sciences 2014 ’ ... key insights pertaining to the benefits in the knowledge ... Shanler and Stephen Davies, “The use of these systems ... scientific stakeholders, and support collaboration and innovation strategies as ...
(Date:9/23/2014)... September 23, 2014 Dr. Williams says, ... book on healthcare offers a three phase process that ... healthcare delivery system that would go far beyond anything ... regarding the delivery of healthcare.” , “Every effort to ... failed to provide discernable progress throughout that system because ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Pearl's Premium ... breakthrough in drought tolerant grass seed this week with ... seed. The announcement coincides with the fact that it ... Spring as many believe. , As of the ... and favorable reviews by industry experts and the media ...
Breaking Biology Technology:Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Pearl's Premium Ultra Low Maintenance Lawn Seed Announces A Major Breakthrough In Drought Tolerant Grass Seed 2
... , , ... ("China Pharma") (NYSE Amex: CPHI ), which develops,manufactures, and ... present at the Brean Murray, Carret & Co. 2009 China,Growth ... Broadway,hotel in New York. Management is scheduled to present ...
... , CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE ... top ten best selling science books , SEATTLE, Nov. 17 ... new book about the controversial theory of intelligent design made Amazon.com,s ... as the world marks 150 years since Charles Darwin published his ...
... , KVISTGARD, ... today that BARDA (Biomedical Advanced Research and,Development Authority) has ... of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine,with ... The contract provides funds to ...
Cached Biology Technology:China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference 2Intelligent Design Book Delivers Blow to Darwin 2US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine 2US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine 3
(Date:9/23/2014)... Ill. Antarctic fishes that manufacture their own ... Ocean also suffer an unfortunate side effect, researchers ... their bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences ... an undesirable consequence of the evolution of antifreeze ...
(Date:9/23/2014)... man has domesticated animals, selecting the best traits ... offer an intriguing animal to examine adaptation to ... of selected breeding and a wealth of livestock ... kind study that combined molecular and environmental data, ... for genes under environmental selection from domesticated sheep ...
(Date:9/23/2014)... an athlete,s moving body relies on an orchestrated response of ... intersecting planes literally the geometry of a critical ... more than just a footfall error at the root of ... or anterior cruciate ligament tear. In fact, size of ... knee joint and volume of the ACL combine to ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 3Being sheepish about climate adaptation 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3
... is allowing scientists to better understand the movement of cells ... microenvironment. In a recent article published in Disease Models ... colleagues used optimized methods of laser microscopy to track the ... cancer. As a tumor grows, it triggers ...
... Activity in Identity ... Management and Biometrics, FALLS CHURCH, Va., Sept. ... relocating the CSC Identity Labs headquarters from Camp,Hill, Pa., to Fairmont, ... alignment with the federal government,s presence in the,I-79 High Technology Corridor, ...
... FL (September 16, 2008)- A team of scientists headed by neuroscientist ... grant by the National Institute of Health (NIH), to develop a ... injury. Dr. Chiba, a professor at the University of Miami,s Department ... groundbreaking process to enhance synapse formation or nerve regeneration., ...
Cached Biology News:CSC Identity Labs Headquarters Relocates to West Virginia 2CSC Identity Labs Headquarters Relocates to West Virginia 3NIH EUREKA grant awarded to University of Miami scientist 2
... AmpliTaq DNA Polymerase is the most thoroughly ... a testimony to its overall utility and ... it ideal for PCR applications. , ... results. ,, AmpliTaq DNA Polymerase is ...
... DNA Polymerase is a versatile and easy-to ... PCR applications. GCpro Taq DNA Polymerase is ... E. coli, containing the DNA polymerase I ... a highly processive 5'-3' DNA polymerase activity. ...
Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
APO(a) EIA Sample Size: 25 l...
Biology Products: